Atlas Trials

A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)

Clinical trial NCT02024789 · COMPLETED

Trial details

NCT number
NCT02024789
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Down Syndrome
Start date
2014-05-05
Primary completion
2016-05-04
Enrollment
173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.